Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

This study has been completed.
Sponsor:
Information provided by:
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00135434
First received: August 25, 2005
Last updated: April 7, 2011
Last verified: November 2009

August 25, 2005
April 7, 2011
September 2004
June 2005   (final data collection date for primary outcome measure)
Insulin sensitivity by euglycemic hyperinsulinemic clamp method
Not Provided
Complete list of historical versions of study NCT00135434 on ClinicalTrials.gov Archive Site
  • Insulin sensitivity by oral glucose tolerance
  • Lipids and lipoproteins
Not Provided
Not Provided
Not Provided
 
Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

This study examined the effects of two commonly prescribed HIV drugs on the way the body metabolizes glucose, insulin and fat.

Not Provided
Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
HIV Infections
Drug: Atazanavir/Ritonavir/Lopinavir/ritonavir
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
25
June 2005
June 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy volunteers
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00135434
AI424-130
Not Provided
Study Director, Bristol-Myers Squibb
Bristol-Myers Squibb
Not Provided
Study Director: Bristol-Myers Squibb Bristol-Myers Squibb
Bristol-Myers Squibb
November 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP